129
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Biomarkers of exposure, effect, and susceptibility in workers exposed to chloronitrobenzenes

, , , , , & show all
Pages 721-730 | Received 30 Nov 2015, Accepted 24 Mar 2016, Published online: 27 Apr 2016

References

  • Beland FA, Kadlubar FF. (1990). Metabolic activation and DNA adducts of aromatic amines and nitroaromatic hydrocarbons. In: Cooper CS, ed. Chemical carcinogenesis and mutagenesis I. Berlin: Springer, 267–325.
  • Bell DA, Taylor JA, Butler MA, et al. (1993). Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans. Carcinogenesis 14:1689–92.
  • Bell DA, Badawi AF, Lang NP, et al. (1995). Polymorphism in the N-acetyltransferase 1 (NAT1) polyadenylation signal: association of NAT1 10 allele with higher N-acetylation activity in bladder and colon tissue. Cancer Res 55:5226–9.
  • Bucher J. (1993). NTP technical report on the toxicity studies of 2-chloronitrobenzene (CAS No. 88-73-3) and 4-chloronitrobenzene (CAS No. 100-00-5) administered by inhalation to F344/N rats and B6C3F1 mice. Toxic Rep Ser 33:1–F25.
  • Bus JS, Popp JA. (1987). Perspectives on the mechanism of action of the splenic toxicity of aniline and structurally-related compounds. Food Chem Toxicol 25:619–26.
  • Chen H, Sandler DP, Taylor JA, et al. (1996). Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect. Lancet 347:295–7.
  • Coles BF, Kadlubar FF. (2003). Detoxification of electrophilic compounds by glutathione S-transferase catalysis: determinants of individual response to chemical carcinogens and chemotherapeutic drugs? Biofactors 17:115–30.
  • Delclos KB, Kadlubar FF. (1997). Carcinogenic aromatic amines and amides. In: Bowden GT, Fischer SM, eds. Comprehensive toxicology, vol. 12. Chemical carcinogens and anticarcinogens. New York: Elsevier Science, 141–70.
  • Feltes J, Levsen K, Volmer D, Spiekermann M. (1990). Gas chromatographic and mass spectrometric determination of nitroaromatics in water. J Chromatogr 518:21–40.
  • Glatt H. (2000). Sulfotransferases in the bioactivation of xenobiotics. Chem Biol Interact 129:141–70.
  • Goldstein RS, Rickert DE. (1984). Macromolecular covalent binding of [14C]nitrobenzene in the erythrocyte and spleen of rats and mice. Chem Biol Interact 50:27–37.
  • Hirvonen A, Saarikoski ST, Linnainmaa K, et al. (1996). Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders. J Natl Cancer Inst 88:1853–6.
  • Humphreys WG, Kadlubar FF, Guengerich FP. (1992). Mechanism of C8 alkylation of guanine residues by activated arylamines: evidence for initial adduct formation at the N7 position. Proc Natl Acad Sci USA 89:8278–82.
  • ISCN. (1985). An international system for human cytogenetic nomenclature (1985) ISCN 1985. Report of the Standing Committee on human cytogenetic nomenclature. Birth Defects Orig Artic Ser 21:1–117.
  • Jones CR, Liu YY, Sepai O, et al. (2005). Hemoglobin adducts in workers exposed to nitrotoluenes. Carcinogenesis 26:133–43.
  • Jones CR, Liu YY, Sepai O, et al. (2006). Internal exposure, health effects, and cancer risk of humans exposed to chloronitrobenzene. Environ Sci Technol 40:387–94.
  • Jones CR, Sepai O, Liu YY, et al. (2007). Urinary metabolites and health effects in workers exposed chronically to chloronitrobenzene. Biomarkers 12:1–20.
  • Kiese M. (1974). Methemoglobinemia: a comprehensivetreatise. Cleveland, OH: CRC Press, Inc.
  • Kim D, Guengerich FP. (2005). Cytochrome P450 activation of arylamines and heterocyclic amines. Annu Rev Pharmacol Toxicol 45:27–49.
  • Neumann HG, Birner G, Kowallik P, et al (1993). Hemoglobin adducts of N-substituted aryl compounds in exposure control and risk assessment. Environ Health Perspect 99:65–9.
  • Nordenson I, Mild KH, Järventaus H, et al. (2001). Chromosomal aberrations in peripheral lymphocytes of train engine drivers. Bioelectromagnetics 22:306–15.
  • Rickert DE, Held SD. (1990). Metabolism of chloronitrobenzenes by isolated rat hepatocytes. Drug Metab Dispos 18:5–9.
  • Riffelmann M, Muller G, Schmieding W, et al. (1995). Biomonitoring of urinary aromatic amines and arylamine hemoglobin adducts in exposed workers and nonexposed control persons. Int Arch Occup Environ Health 68:36–43.
  • Ringe D, Turesky RJ, Skipper PL, Tannenbaum SR. (1988). Structure of the single stable hemoglobin adduct formed by 4-aminobiphenyl in vivo. Chem Res Toxicol 1:22–4.
  • Saarikoski ST, Voho A, Reinikainen M, et al. (1998). Combined effect of polymorphic GST genes on individual susceptibility to lung cancer. Int J Cancer 77:516–21.
  • Sabbioni G. (1994). Hemoglobin binding of nitroarenes and quantitative structure-activity relationships. Chem Res Toxicol 7:267–74.
  • Sabbioni G, Jones CR. (2002). Biomonitoring of arylamines and nitroarenes. Biomarkers 7:347–421.
  • Sabbioni G, Jones CR, Sepai O, et al. (2006). Biomarkers of exposure, effect, and susceptibility in workers exposed to nitrotoluenes. Cancer Epidemiol Biomarkers Prev 15:559–66.
  • Sabbioni G, Liu YY, Yan H, Sepai O. (2005). Hemoglobin adducts, urinary metabolites and health effects in 2,4,6-trinitrotoluene exposed workers. Carcinogenesis 26:1272–9.
  • Sabbioni G, Sepai O, Norppa H, et al. (2007). Comparison of biomarkers in workers exposed to 2,4,6-trinitrotoluene. Biomarkers 12:21–37.
  • Skipper PL, Kim MY, Sun HL, et al. (2010). Monocyclic aromatic amines as potential human carcinogens: old is new again. Carcinogenesis 31:50–8.
  • Törnqvist M, Fred C, Haglund J, et al. (2002). Protein adducts: quantitative and qualitative aspects of their formation, analysis and applications. J Chromatogr B Analyt Technol Biomed Life Sci 778:279–308.
  • Turesky RJ, Le Marchand L. (2011). Metabolism and biomarkers of heterocyclic aromatic amines in molecular epidemiology studies: lessons learned from aromatic amines. Chem Res Toxicol 24:1169–214.
  • United Nations Environment Programme. (2003a). United Nations Environment Programme (Processed by UNEP Chemicals). OECD Screening Information Data Set, High Production Volume Chemicals:1-Chloro-2-nitrobenzene; UNEP. Nairobi, Kenya, pp 1-106.
  • United Nations Environment Programme. (2003b). United Nations Environment Programme (Processed by UNEP Chemicals). OECD Screening Information Data Set, High Production Volume Chemicals:1-Chloro-4-nitrobenzene. Nairobi, Kenya: UNEP. 1–168.
  • U.S. EPA. (2002a). Provisional Peer Reviewed Toxicity Values Derivation Support Document for o-Chloronitrobenzene (2-Chloronitrobenzene); SRCTR-02-036/09-10-2002; 2002. Washington, DC: Environmental Protection Agency, Office of Superfund Remediation and Technology Innovation.
  • U.S. EPA. (2002b). Provisional Peer Reviewed Toxicity Values PPRTV Derivation Support Document for p-Chloronitrobenzene (4-Chloronitrobenzene); SRCTR-02-037/09-05-2002.: Environmental Protection Agency. Washington, DC: Office of Superfund Remediation and Technology Innovation.
  • van Welie RT, van Dijck RG, Vermeulen NP, van Sittert NJ (1992). Mercapturic acids, protein adducts, and DNA adducts as biomarkers of electrophilic chemicals. Crit Rev Toxicol 22:271–306.
  • Yoshida T. (1994). Pharmacokinetic study of p-chloronitrobenzene in rat. Drug Metab Dispos 22:275–80.
  • Yoshida T, Tabuchi T, Andoh K. (1993). Pharmacokinetic study of p-chloronitrobenzene in humans suffering from acute poisoning. Drug Metab Dispos 21:1142–6.
  • Yurawecz MP, Puma BJ. (1983). Identification of chlorinated nitrobenzene residues in Mississippi River fish. J Assoc Off Anal Chem 66:1345–52.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.